STRONGBRIDGE BIOPHARMA plc Asset Impairment Charges
STRONGBRIDGE BIOPHARMA plc reported Asset Impairment Charges of $5.23 million for the 3-month period ending 2016-06-30, per its 6-K filed 2017-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2017-08-07
- STRONGBRIDGE BIOPHARMA plc asset impairment charges for the quarter ending 2016-06-30 was $5.23M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month |
|---|---|---|
| 2016-06-30 | $5.23M 6-K · filed 2017-08-07 | $5.23M 6-K · filed 2017-08-07 |